GABA-benzodiazepine receptor complex: focus on receptor subtypes and cyclopyrrolone drugs.
D000818:Animals; D014151:Anti-Anxiety Agents / Q000378:metabolism; D001667:Binding, Competitive; D001643:Bridged Bicyclo Compounds / Q000378:metabolism; D019086:Bridged Bicyclo Compounds, Heterocyclic; D002712:Chlorides / Q000378:metabolism; D003292:Convulsants / Q000378:metabolism; D006160:Guanosine Triphosphate / Q000378:metabolism; D006801:Humans; D007473:Ion Channels; D010879:Piperazines / Q000378:metabolism; D011724:Pyridazines / Q000378:metabolism; D051381:Rats; D011963:Receptors, GABA-A / Q000378:metabolism*
D014151:Anti-Anxiety Agents; D001643:Bridged Bicyclo Compounds; D019086:Bridged Bicyclo Compounds, Heterocyclic; D002712:Chlorides; D003292:Convulsants; D007473:Ion Channels; D010879:Piperazines; D011724:Pyridazines; D011963:Receptors, GABA-A; C021604:CL 218872; C037476:tert-butylbicyclophosphorothionate; D006160:Guanosine Triphosphate